The objective of this study was to describe the prevalence of different T cell populations, including CD4+ and CD8 + lymphocytes, T regulatory cells, and IL-17 positive lymphocytes in dogs with IMHA or ITP at diagnosis and up to 4 days following initiation of treatment. This evidence concerns the gene CD8A and autoimmune thrombocytopenic purpura.